remdesivir

Peter Pitts, the former FDA Associate Commissioner, said industry, academia and government are working together to make an effective coronavirus vaccine available by early 2021. But the rollout is expected to be complicated, with more than one vaccine likely available and questions about which groups should be prioritized to get the vaccine first.

Health experts on Wednesday slammed the U.S. decision to hog nearly the entire global supply of remdesivir, the only drug licensed so far to treat COVID-19, warning that type of selfish behavior sets a dangerous precedent for attempts to share scarce treatments amid the pandemic. The U.S. government announced Tuesday that President Donald Trump had struck “an amazing deal”...

Pharmaceutical giant Gilead says it plans to charge at least $2,300 for a single treatment course of Remdesivir, a drug shown to shorten recovery time for severely ill coronavirus patients.

Results from a phase three trial show that Remdesivir helps recovery in moderately-ill coronavirus patients.

A new study shows patients taking Remdesivir — an experimental drug found to work against the new coronavirus — may not need to take it as long as previously thought, suggesting more patients could be treated with it. The international study, published Wednesday in the New England Journal of Medicine, found there’s no significant difference between those who were treated…

It came as a surprise to the Waters family when their patriarch tested positive for COVID-19. He was taken to the hospital where they found pneumonia in both of his lungs.

This Memorial Day was unlike any other. Although states have begun to ease their stay-at-home orders, many restrictions on public spaces and social gatherings remained in place for the unofficial start of summer.

As lockdowns ease across the United States, Americans are getting out of the house to celebrate the unofficial start of the summer. President Donald Trump himself marked Memorial Day weekend with a round of golf — his first in more than two months.

As lockdowns ease across the United States, millions of Americans are set to take tentative steps outdoors to celebrate Memorial Day. But public health officials are still concerned that if people congregate in crowds or engage in other risky behavior, the coronavirus could come roaring back.

Dr. Anoop Maheshwari had been treating COVID-19 patients for more than 12 hours a day. When the 59-year-old pulmonary specialist from Covina contracted the disease himself, he thought it would kill him. “I talked with my mother, I talked with my wife, I talked with my two children, my sister, father – I talked with everyone,” he said. “I told…

Authorizing this drugs is, for now, about providing relief to patients with coronavirus. It is not a cure or a vaccine. Patrick Healy reports for the NBC4 News at 4 p.m. Friday, May 2, 2020.

Dr. Anoop Maheshwari went from treating coronavirus patients to almost dying from the virus. He says being part of the clinical trial for the drug remdesivir helped save his life. Beverly White reports for the NBC4 News at 11 p.m. Friday, May 1, 2020.

U.S. regulators will allow emergency use of the first drug that appears to help some coronavirus patients recover faster

News that an experimental drug seems to be the first effective treatment for the new coronavirus has unleashed a flurry of interest from doctors and patients — and questions about how soon it might be available.

Dr. Anthony Fauci explains how a new study of the drug Remdesivir, which has been used in a test to treat coronavirus patients, is so important for finding more treatments to help patients.

Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were discharged from the hospital within two weeks. The company also said another trial by the National Institute of Allergy and Infectious Diseases met its main goal. It did...

A drug developed to treat the Ebola virus is now being heralded by the White House as a possible “game changer” in the search for a COVID-19 treatment. But UCLA researchers involved in the clinical trials for Remdesivir are not making any conclusions yet. “It’s definitely not a silver bullet or magic bullet,” Dr. Otto Yang of UCLA Medical...